Metformin alone and in combination with sitagliptin induces depression and impairs quality of life in type 2 diabetes mellitus patients: An observational study.

Athar, Mohammed; Garg, Aakriti; Khan, Mohd Ashif; Parveen, Rizwana; Kohli, Sunil; Vohora, Divya

Athar, Mohammed; Garg, Aakriti; Khan, Mohd Ashif; Parveen, Rizwana; Kohli, Sunil; Vohora, Divya.

Int J Clin Pharmacol Ther ; 61(3): 102-110, 2023 Mar.

Article in En | MEDLINE | ID: mdl-36519927

Subject(s)

Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Metformin; Humans; Sitagliptin Phosphate/adverse effects; Diabetes Mellitus, Type 2/diagnosis; Diabetes Mellitus, Type 2/drug therapy; Metformin/adverse effects; Quality of Life; Depression/chemically induced; Depression/diagnosis; Glycated Hemoglobin; Hypoglycemic Agents/adverse effects; Dipeptidyl-Peptidase IV Inhibitors/adverse effects; Drug Therapy, Combination; Blood Glucose

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Diabetes Mellitus, Type 2 / Dipeptidyl-Peptidase IV Inhibitors / Metformin Type of study: Observational_studies Limits: Humans Language: En Journal: Int J Clin Pharmacol Ther Journal subject: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2023 Type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google